Aprio Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$901K Sell
1,796
-166
-8% -$79.7K 0.04% 251
2026
Q1
$964K Buy
1,962
+235
+14% +$128K 0.05% 216
2025
Q4
$1.04M Buy
1,727
+348
+25% +$197K 0.06% 190
2025
Q3
$669K Buy
1,379
+851
+161% +$396K 0.07% 171
2025
Q2
$214K Sell
528
-1,033
-66% -$432K 0.02% 374
2025
Q1
$777K Buy
1,561
+539
+53% +$292K 0.1% 130
2024
Q4
$532K Buy
1,022
+155
+18% +$85.2K 0.08% 131
2024
Q3
$536K Buy
867
+75
+9% +$44.4K 0.09% 121
2024
Q2
$438K Buy
792
+290
+58% +$166K 0.08% 118
2024
Q1
$292K Buy
+502
New +$282K 0.06% 158

Other funds holding TMO

Aprio Wealth Management's TMO Position: Q2 2026 in Review

Aprio Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 8.5% in Q2 2026, selling an estimated $79.7K and leaving 1,796 shares worth $901K. The position accounts for 0.04% of the portfolio, ranked #251.

Aprio Wealth Management first reported a position in TMO in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.04M in Q4 2025. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Aprio Wealth Management held 1,796 shares of Thermo Fisher Scientific worth $901K as of Q2 2026.
  • Aprio Wealth Management sold 166 Thermo Fisher Scientific shares in Q2 2026, an estimated $79.7K.
  • Thermo Fisher Scientific made up 0.04% of Aprio Wealth Management's portfolio in Q2 2026, its #251 holding.
  • Aprio Wealth Management first reported a position in Thermo Fisher Scientific in Q1 2024 and has held it in 10 quarters since.
  • Aprio Wealth Management's Thermo Fisher Scientific position peaked at $1.04M in Q4 2025.
  • 794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Aprio Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.